Siemens Healthcare has received approval from the Food and Drug Administration (FDA) for its new 16-slice computed tomography (CT) scanner, SOMATOM Scope.
The SOMATOM Scope is available in two configurations, Scope and Scope Power.
It can be used for radiology practices and specialty practices such as orthopedics and urology in community hospitals and critical access hospitals, as well as in veternary medicine.
Siemens Healthcare computed tomography and radiation oncology business management vice-president Murat Gungor said: "By adding the Scope to our portfolio of SOMATOM CT scanners, we help bring CT imaging closer to the point of care, enabling our customers to focus on what matters the most: improving care through more informed, timely clinical decision-making.
"The SOMATOM Scope helps to ensure that a greater segment of the patient population has access to innovative technologies while enabling facilities to help control costs as well as save time and effort throughout their daily routine."
SOMATOM Scope has been developed for use in oncological examinations, interventional radiology, and vascular imaging, while SOMATOM Scope Power can be used for higher volume clinical settings.
The new system features Iterative Reconstruction in Image Space (IRIS) technology, which enhances image reconstruction.
The system’s Fully Assisting Scanner Technology (FAST) and Combined Applications to Reduce Exposure (CARE) applications helps in reducing radiation exposure and standardizes CT imaging process.